97 related articles for article (PubMed ID: 16977628)
1. NR4A2 genetic variation in sporadic Parkinson's disease: a genewide approach.
Healy DG; Abou-Sleiman PM; Ahmadi KR; Gandhi S; Muqit MM; Bhatia KP; Quinn NP; Lees AJ; Holton JL; Revesz T; Wood NW
Mov Disord; 2006 Nov; 21(11):1960-3. PubMed ID: 16977628
[TBL] [Abstract][Full Text] [Related]
2. Nuclear receptor NR4A2 IVS6 +18insG and brain derived neurotrophic factor (BDNF) V66M polymorphisms and risk of Taiwanese Parkinson's disease.
Chen CM; Chen IC; Chang KH; Chen YC; Lyu RK; Liu YT; Hu FJ; Chao CY; Lee-Chen GJ; Wu YR
Am J Med Genet B Neuropsychiatr Genet; 2007 Jun; 144B(4):458-62. PubMed ID: 17427185
[TBL] [Abstract][Full Text] [Related]
3. Association of polymorphisms and reduced expression levels of the NR4A2 gene with Parkinson's disease in a Mexican population.
Ruiz-Sánchez E; Yescas P; Rodríguez-Violante M; Martínez-Rodríguez N; Díaz-López JN; Ochoa A; Valdes-Rojas SS; Magos-Rodríguez D; Rojas-Castañeda JC; Cervantes-Arriaga A; Canizales-Quinteros S; Rojas P
J Neurol Sci; 2017 Aug; 379():58-63. PubMed ID: 28716280
[TBL] [Abstract][Full Text] [Related]
4. Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD study.
Karamohamed S; Golbe LI; Mark MH; Lazzarini AM; Suchowersky O; Labelle N; Guttman M; Currie LJ; Wooten GF; Stacy M; Saint-Hilaire M; Feldman RG; Liu J; Shoemaker CM; Wilk JB; DeStefano AL; Latourelle JC; Xu G; Watts R; Growdon J; Lew M; Waters C; Vieregge P; Pramstaller PP; Klein C; Racette BA; Perlmutter JS; Parsian A; Singer C; Montgomery E; Baker K; Gusella JF; Herbert A; Myers RH
Mov Disord; 2005 Sep; 20(9):1188-91. PubMed ID: 15966003
[TBL] [Abstract][Full Text] [Related]
5. Mutations in NR4A2 associated with familial Parkinson disease.
Le WD; Xu P; Jankovic J; Jiang H; Appel SH; Smith RG; Vassilatis DK
Nat Genet; 2003 Jan; 33(1):85-9. PubMed ID: 12496759
[TBL] [Abstract][Full Text] [Related]
6. NR4A2 genetic variation and Parkinson's disease: Evidence from a systematic review and meta-analysis.
Liu H; Liu H; Li T; Cui J; Fu Y; Ren J; Sun X; Jiang P; Yu S; Li C
Neurosci Lett; 2017 May; 650():25-32. PubMed ID: 28385514
[TBL] [Abstract][Full Text] [Related]
7. NURR1 promoter polymorphisms: Parkinson's disease, schizophrenia, and personality traits.
Carmine A; Buervenich S; Galter D; Jönsson EG; Sedvall GC; Farde L; Gustavsson JP; Bergman H; Chowdari KV; Nimgaonkar VL; Anvret M; Sydow O; Olson L
Am J Med Genet B Neuropsychiatr Genet; 2003 Jul; 120B(1):51-7. PubMed ID: 12815740
[TBL] [Abstract][Full Text] [Related]
8. Genetic analysis of NR4A2 gene in a large population of Han Chinese patients with Parkinson's disease.
Liu H; Tao Q; Deng H; Ming M; Ding Y; Xu P; Chen S; Song Z; Le W
Eur J Neurol; 2013 Mar; 20(3):584-587. PubMed ID: 22827504
[TBL] [Abstract][Full Text] [Related]
9. Extended mutation analysis and association studies of Nurr1 (NR4A2) in Parkinson disease.
Hering R; Petrovic S; Mietz EM; Holzmann C; Berg D; Bauer P; Woitalla D; Müller T; Berger K; Krüger R; Riess O
Neurology; 2004 Apr; 62(7):1231-2. PubMed ID: 15079038
[No Abstract] [Full Text] [Related]
10. Characterisation of a novel NR4A2 mutation in Parkinson's disease brain.
Sleiman PM; Healy DG; Muqit MM; Yang YX; Van Der Brug M; Holton JL; Revesz T; Quinn NP; Bhatia K; Diss JK; Lees AJ; Cookson MR; Latchman DS; Wood NW
Neurosci Lett; 2009 Jun; 457(2):75-9. PubMed ID: 19429166
[TBL] [Abstract][Full Text] [Related]
11. Point mutations in exon 1 of the NR4A2 gene are not a major cause of familial Parkinson's disease.
Zimprich A; Asmus F; Leitner P; Castro M; Bereznai B; Homann N; Ott E; Rutgers AW; Wieditz G; Trenkwalder C; Gasser T
Neurogenetics; 2003 Aug; 4(4):219-20. PubMed ID: 12827450
[No Abstract] [Full Text] [Related]
12. Haplotypes of the NR4A2/NURR1 gene and cardiovascular disease: the Rotterdam Study.
Kardys I; van Tiel CM; de Vries CJ; Pannekoek H; Uitterlinden AG; Hofman A; Witteman JC; de Maat MP
Hum Mutat; 2009 Mar; 30(3):417-23. PubMed ID: 19156841
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial transcription factor A variants and the risk of Parkinson's disease.
Gaweda-Walerych K; Safranow K; Maruszak A; Bialecka M; Klodowska-Duda G; Czyzewski K; Slawek J; Rudzinska M; Styczynska M; Opala G; Drozdzik M; Kurzawski M; Szczudlik A; Canter JA; Barcikowska M; Zekanowski C
Neurosci Lett; 2010 Jan; 469(1):24-9. PubMed ID: 19925850
[TBL] [Abstract][Full Text] [Related]
14. Association between epidermal growth factor receptor gene polymorphisms and susceptibility to Parkinson's disease.
Jin J; Xue L; Bai X; Zhang X; Tian Q; Xie A
Neurosci Lett; 2020 Sep; 736():135273. PubMed ID: 32712352
[TBL] [Abstract][Full Text] [Related]
15. [Association of the polymorphisms in NURR1 gene with Parkinson's disease].
Wu Y; Peng R; Chen W; Zhang J; Li T; Wang Y; Gou Y; Yuan G
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Dec; 25(6):693-6. PubMed ID: 19065535
[TBL] [Abstract][Full Text] [Related]
16. Systematic genetic analysis of the PITX3 gene in patients with Parkinson disease.
Guo Y; Le WD; Jankovic J; Yang HR; Xu HB; Xie WJ; Song Z; Deng H
Mov Disord; 2011 Aug; 26(9):1729-32. PubMed ID: 21469209
[TBL] [Abstract][Full Text] [Related]
17. Altered NR4A Subfamily Gene Expression Level in Peripheral Blood of Parkinson's and Alzheimer's Disease Patients.
Montarolo F; Perga S; Martire S; Navone DN; Marchet A; Leotta D; Bertolotto A
Neurotox Res; 2016 Oct; 30(3):338-44. PubMed ID: 27159982
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the role of Nurr1 in a large sample of familial Parkinson's disease.
Nichols WC; Uniacke SK; Pankratz N; Reed T; Simon DK; Halter C; Rudolph A; Shults CW; Conneally PM; Foroud T;
Mov Disord; 2004 Jun; 19(6):649-55. PubMed ID: 15197702
[TBL] [Abstract][Full Text] [Related]
19. Absence of NR4A2 exon 1 mutations in 108 families with autosomal dominant Parkinson disease.
Ibáñez P; Lohmann E; Pollak P; Durif F; Tranchant C; Agid Y; Dürr A; Brice A;
Neurology; 2004 Jun; 62(11):2133-4. PubMed ID: 15184637
[No Abstract] [Full Text] [Related]
20. Association of MAPT haplotype-tagging SNPs with sporadic Parkinson's disease.
Vandrovcova J; Pittman AM; Malzer E; Abou-Sleiman PM; Lees AJ; Wood NW; de Silva R
Neurobiol Aging; 2009 Sep; 30(9):1477-82. PubMed ID: 18162161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
